CHINA PHARMA HOLDINGS, INC. Depreciation
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Depreciation of $150.33 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. depreciation for the quarter ending 2026-06-30 was $150.33K, a 8.06% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. depreciation for the quarter ending 2026-03-31 was $155.29K, a 9.51% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. depreciation for the quarter ending 2025-12-31 was $59.93K, a 80.53% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. depreciation for the quarter ending 2025-09-30 was $158.08K, a 67.95% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. depreciation for fiscal 2025 was $652.03K, a 69.96% decline from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. depreciation for fiscal 2024 was $2.17M, a 14.19% decline from fiscal 2023.
- CHINA PHARMA HOLDINGS, INC. depreciation for fiscal 2023 was $2.53M, a 5.03% decline from fiscal 2022.
- CHINA PHARMA HOLDINGS, INC. depreciation for fiscal 2022 was $2.66M, a 12.65% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed | Depreciation 27 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $150.33K 10-Q · filed 2026-08-14 | $305.62K 10-Q · filed 2026-08-14 | $365.54K derived: sum of 3 quarters · filed 2026-08-14 | $523.62K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | $155.29K 10-Q · filed 2026-05-15 | $215.22K derived: sum of 2 quarters · filed 2026-05-15 | $373.29K derived: sum of 3 quarters · filed 2026-05-15 | $536.79K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | $59.93K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $218.00K derived: sum of 2 quarters · filed 2026-04-01 | $381.51K derived: sum of 3 quarters · filed 2026-08-14 | $652.03K 10-K · filed 2026-04-01 | |||||
| 2025-09-30 | $158.08K 10-Q · filed 2025-11-12 | $321.58K derived: sum of 2 quarters · filed 2026-08-14 | $592.10K 10-Q · filed 2025-11-12 | $800.92K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | $163.50K 10-Q · filed 2026-08-14 | $335.10K 10-Q · filed 2026-08-14 | $642.85K derived: sum of 3 quarters · filed 2026-08-14 | $1.14M derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | $171.60K 10-Q · filed 2026-05-15 | $479.34K derived: sum of 2 quarters · filed 2026-05-15 | $972.52K derived: sum of 3 quarters · filed 2026-05-15 | $1.61M derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | $307.74K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $800.92K derived: sum of 2 quarters · filed 2026-04-01 | $1.44M derived: sum of 3 quarters · filed 2026-04-01 | $2.17M 10-K · filed 2026-04-01 | |||||
| 2024-09-30 | $493.18K 10-Q · filed 2025-11-12 | $592.10K 10-Q · filed 2024-11-13 | $1.13M derived: sum of 2 quarters · filed 2025-11-12 | $1.86M 10-Q · filed 2025-11-12 | $2.40M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $636.72K 10-Q · filed 2025-08-14 | $1.27M 10-Q · filed 2025-08-14 | $1.91M derived: sum of 3 quarters · filed 2025-08-14 | $2.54M derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | $636.72K 10-Q · filed 2025-05-14 | $1.27M derived: sum of 2 quarters · filed 2025-05-14 | $1.90M derived: sum of 3 quarters · filed 2025-05-14 | $2.54M derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2023-12-31 | $633.58K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $1.26M derived: sum of 2 quarters · filed 2025-03-31 | $1.91M derived: sum of 3 quarters · filed 2025-03-31 | $2.53M 10-K · filed 2025-03-31 | $2.53M 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | $630.58K 10-Q · filed 2024-11-13 | $1.27M derived: sum of 2 quarters · filed 2024-11-13 | $1.90M 10-Q · filed 2024-11-13 | $1.90M 10-Q · filed 2023-11-13 | $2.54M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $640.98K 10-Q · filed 2024-08-14 | $1.27M 10-Q · filed 2024-08-14 | $1.91M derived: sum of 3 quarters · filed 2024-08-14 | $2.57M derived: sum of 4 quarters · filed 2024-08-14 | |||||
| 2023-03-31 | $640.98K 10-Q · filed 2023-08-14 | $624.72K 10-Q · filed 2023-05-12 | $1.27M derived: sum of 2 quarters · filed 2024-04-01 | $1.93M derived: sum of 3 quarters · filed 2024-04-01 | $2.60M derived: sum of 4 quarters · filed 2024-04-01 | ||||
| 2022-12-31 | $630.78K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.29M derived: sum of 2 quarters · filed 2024-04-01 | $1.96M derived: sum of 3 quarters · filed 2024-04-01 | $2.66M 10-K · filed 2024-04-01 | |||||
| 2022-09-30 | $655.39K 10-Q · filed 2023-11-13 | $1.33M derived: sum of 2 quarters · filed 2023-11-13 | $2.03M 10-Q · filed 2023-11-13 | $2.70M derived: sum of 4 quarters · filed 2023-11-13 | |||||
| 2022-06-30 | $673.93K 10-Q · filed 2022-08-11 | $1.38M 10-Q · filed 2023-08-14 | $1.38M 10-Q · filed 2022-08-11 | $2.05M derived: sum of 3 quarters · filed 2023-08-14 | $3.02M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $673.93K 10-Q · filed 2023-08-14 | $703.88K 10-Q · filed 2022-05-12 | $1.38M derived: sum of 2 quarters · filed 2023-08-14 | $2.34M derived: sum of 3 quarters · filed 2023-08-14 | $3.03M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2021-12-31 | $701.10K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.67M derived: sum of 2 quarters · filed 2023-03-30 | $2.36M derived: sum of 3 quarters · filed 2023-03-30 | $3.05M 10-K · filed 2023-03-30 | |||||
| 2021-09-30 | $966.96K 10-Q · filed 2022-11-14 | $1.66M derived: sum of 2 quarters · filed 2022-11-14 | $2.35M 10-Q · filed 2022-11-14 | $3.04M derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | $690.94K 10-Q · filed 2022-08-11 | $1.38M 10-Q · filed 2022-08-11 | $2.07M derived: sum of 3 quarters · filed 2022-08-11 | $2.74M derived: sum of 4 quarters · filed 2022-08-11 | |||||
| 2021-03-31 | $690.71K 10-Q · filed 2022-05-12 | $1.38M derived: sum of 2 quarters · filed 2022-05-12 | $2.05M derived: sum of 3 quarters · filed 2022-05-12 | $2.69M derived: sum of 4 quarters · filed 2022-05-12 | |||||
| 2020-12-31 | $691.83K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.36M derived: sum of 2 quarters · filed 2022-03-30 | $2.00M derived: sum of 3 quarters · filed 2022-03-30 | $2.64M 10-K · filed 2022-03-30 | |||||
| 2020-09-30 | $664.40K 10-Q · filed 2021-11-12 | $1.30M derived: sum of 2 quarters · filed 2021-11-12 | $1.95M 10-Q · filed 2021-11-12 | $2.61M derived: sum of 4 quarters · filed 2021-11-12 | |||||
| 2020-06-30 | $640.47K 10-Q · filed 2021-08-13 | $1.29M 10-Q · filed 2021-08-13 | $1.95M derived: sum of 3 quarters · filed 2021-08-13 | $2.62M derived: sum of 4 quarters · filed 2021-08-13 | |||||
| 2020-03-31 | $647.11K 10-Q · filed 2021-05-14 | $1.31M derived: sum of 2 quarters · filed 2021-05-14 | $1.98M derived: sum of 3 quarters · filed 2021-05-14 | $2.75M derived: sum of 4 quarters · filed 2021-05-14 | |||||
| 2019-12-31 | $658.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $1.34M derived: sum of 2 quarters · filed 2021-03-26 | $2.10M derived: sum of 3 quarters · filed 2021-03-26 | $2.87M 10-K · filed 2021-03-26 | |||||
| 2019-09-30 | $677.39K 10-Q · filed 2020-11-13 | $1.44M derived: sum of 2 quarters · filed 2020-11-13 | $2.21M 10-Q · filed 2020-11-13 | $2.95M derived: sum of 4 quarters · filed 2020-11-13 | |||||
| 2019-06-30 | $762.48K 10-Q · filed 2020-08-13 | $1.54M 10-Q · filed 2020-08-13 | $2.27M derived: sum of 3 quarters · filed 2020-08-13 | $3.22M derived: sum of 4 quarters · filed 2020-08-13 | |||||
| 2019-03-31 | $772.86K 10-Q · filed 2020-05-14 | $1.51M derived: sum of 2 quarters · filed 2020-05-14 | $2.45M derived: sum of 3 quarters · filed 2020-05-14 | $3.27M derived: sum of 4 quarters · filed 2020-05-14 | |||||
| 2018-12-31 | $738.20K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.68M derived: sum of 2 quarters · filed 2020-03-30 | $2.50M derived: sum of 3 quarters · filed 2020-03-30 | $3.14M 10-K · filed 2020-03-30 | |||||
| 2018-09-30 | $942.55K 10-Q · filed 2019-11-14 | $1.76M derived: sum of 2 quarters · filed 2019-11-14 | $2.41M 10-Q · filed 2019-11-14 | $3.40M derived: sum of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | $819.52K 10-Q · filed 2019-08-14 | $1.65M 10-Q · filed 2019-08-14 | $2.46M derived: sum of 3 quarters · filed 2019-08-14 | $3.24M derived: sum of 4 quarters · filed 2019-08-14 | |||||
| 2018-03-31 | $827.95K 10-Q · filed 2019-05-14 | $1.64M derived: sum of 2 quarters · filed 2019-05-14 | $2.42M derived: sum of 3 quarters · filed 2019-05-14 | $3.19M derived: sum of 4 quarters · filed 2019-05-14 | |||||
| 2017-12-31 | $811.01K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $1.59M derived: sum of 2 quarters · filed 2019-03-28 | $2.36M derived: sum of 3 quarters · filed 2019-03-28 | $3.13M 10-K · filed 2019-03-28 | |||||
| 2017-09-30 | $779.86K 10-Q · filed 2018-11-14 | $1.55M derived: sum of 2 quarters · filed 2018-11-14 | $2.31M 10-Q · filed 2018-11-14 | $2.75M derived: sum of 4 quarters · filed 2018-11-14 | |||||
| 2017-06-30 | $770.46K 10-Q · filed 2018-08-14 | $1.54M 10-Q · filed 2018-08-14 | $1.97M derived: sum of 3 quarters · filed 2018-08-14 | $2.76M derived: sum of 4 quarters · filed 2018-08-14 | |||||
| 2017-03-31 | $764.61K 10-Q · filed 2018-05-14 | $1.20M derived: sum of 2 quarters · filed 2018-05-14 | $1.99M derived: sum of 3 quarters · filed 2018-05-14 | $2.91M derived: sum of 4 quarters · filed 2018-05-14 | |||||
| 2016-12-31 | $431.71K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $1.22M derived: sum of 2 quarters · filed 2018-04-02 | $2.14M derived: sum of 3 quarters · filed 2018-04-02 | $2.82M 10-K · filed 2018-04-02 | |||||
| 2016-09-30 | $789.15K 10-Q · filed 2017-11-14 | $1.71M derived: sum of 2 quarters · filed 2017-11-14 | $2.38M 10-Q · filed 2017-11-14 | ||||||
| 2016-06-30 | $921.98K 10-Q · filed 2017-08-14 | $1.59M 10-Q · filed 2017-08-14 | |||||||
| 2015-12-31 | $3.28M 10-K · filed 2016-03-30 | ||||||||
| 2014-12-31 | $1.40M 10-K · filed 2016-03-30 | ||||||||
| 2012-09-30 | $638.22K 10-Q · filed 2012-11-14 | ||||||||
| 2011-09-30 | $636.18K 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |